Latest Insider Transactions at Synlogic, Inc. (SYBX)
This section provides a real-time view of insider transactions for Synlogic, Inc. (SYBX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SYNLOGIC, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SYNLOGIC, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2024
|
Mary Beth Dooley Head of Finance |
SELL
Open market or private sale
|
Direct |
79
-0.52%
|
$79
$1.4 P/Share
|
|
Apr 02
2024
|
Antoine Awad Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
372
-1.09%
|
$372
$1.73 P/Share
|
|
Apr 02
2024
|
Mary Beth Dooley Head of Finance |
SELL
Open market or private sale
|
Direct |
188
-1.22%
|
$188
$1.73 P/Share
|
|
Apr 03
2023
|
Michael Vangsted Jensen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,553
-5.16%
|
$0
$0.58 P/Share
|
|
Apr 03
2023
|
Antoine Awad Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,438
-7.93%
|
$0
$0.58 P/Share
|
|
Apr 03
2023
|
Aoife Brennan President and CEO |
SELL
Open market or private sale
|
Direct |
19,042
-6.92%
|
$0
$0.58 P/Share
|
|
May 24
2022
|
Michael Vangsted Jensen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,500
+19.39%
|
$9,500
$1.12 P/Share
|
|
Apr 04
2022
|
Antoine Awad Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,650
-3.16%
|
$5,300
$2.45 P/Share
|
|
Apr 04
2022
|
Aoife Brennan President and CEO |
SELL
Open market or private sale
|
Direct |
8,894
-3.13%
|
$17,788
$2.45 P/Share
|
|
Mar 03
2022
|
Michael Vangsted Jensen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Feb 04
2022
|
Antoine Awad Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,820
+32.75%
|
-
|
|
Feb 04
2022
|
Aoife Brennan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
106,920
+27.33%
|
-
|
|
Apr 20
2021
|
Chau Quang Khuong Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,666,666
+31.08%
|
$4,999,998
$3.0 P/Share
|
|
Apr 20
2021
|
Orbimed Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,666,666
+31.08%
|
$4,999,998
$3.0 P/Share
|
|
Mar 10
2021
|
Antoine Awad Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+28.93%
|
-
|
|
Mar 10
2021
|
Aoife Brennan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
71,250
+28.66%
|
-
|
|
Mar 10
2021
|
Richard J. Riese Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+30.97%
|
-
|
|
Jan 26
2018
|
Orbimed Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
715,000
+26.05%
|
$6,435,000
$9.75 P/Share
|